• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiac Amyloidosis: More Than a Needle in a Haystack.

作者信息

Joynt Maddox Karen E, Zhang Kathleen W

机构信息

Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

Center for Health Economics and Policy, Institute for Public Health, Washington University School of Medicine, St. Louis, Missouri, USA.

出版信息

JACC CardioOncol. 2020 Dec 15;2(5):719-720. doi: 10.1016/j.jaccao.2020.10.008. eCollection 2020 Dec.

DOI:10.1016/j.jaccao.2020.10.008
PMID:34396286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8352289/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06eb/8352289/0d8da8087d38/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06eb/8352289/0d8da8087d38/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06eb/8352289/0d8da8087d38/fx1.jpg

相似文献

1
Cardiac Amyloidosis: More Than a Needle in a Haystack.心脏淀粉样变性：绝非大海捞针那么简单。
JACC CardioOncol. 2020 Dec 15;2(5):719-720. doi: 10.1016/j.jaccao.2020.10.008. eCollection 2020 Dec.
2
Can AI Find the Needle in a Haystack?: The Ongoing Search for Undiagnosed Cardiac Amyloidosis.人工智能能在大海捞针中找到那根针吗？：对未诊断出的心脏淀粉样变的持续探索。
JACC Adv. 2024 Jun 12;3(9):100999. doi: 10.1016/j.jacadv.2024.100999. eCollection 2024 Sep.
3
Healthcare and economic burden of heart failure with amyloidosis: An insight from National Readmission Database.淀粉样变性心肌病的医疗保健与经济负担：来自国家再入院数据库的见解
Am J Med Sci. 2023 Nov;366(5):347-354. doi: 10.1016/j.amjms.2023.08.002. Epub 2023 Aug 8.
4
Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure.患有心脏淀粉样变性的患者在急性心力衰竭后死亡和再次入院的风险更高。
ESC Heart Fail. 2023 Jun;10(3):2042-2050. doi: 10.1002/ehf2.14337. Epub 2023 Apr 13.
5
Abdominal Fat Pad Fine-Needle Aspiration for Diagnosis of Cardiac Amyloidosis in Patients with Non-Ischemic Cardiomyopathy.腹部脂肪垫细针抽吸术在非缺血性心肌病患者心脏淀粉样变性诊断中的应用。
Int Heart J. 2022;63(1):49-55. doi: 10.1536/ihj.21-430.
6
Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.经心内膜心肌活检证实，临床和超声心动图特征对心脏淀粉样变性患者心脏事件发生的影响。
Int J Cardiol. 2014 Oct 20;176(3):753-9. doi: 10.1016/j.ijcard.2014.07.100. Epub 2014 Aug 2.
7
Cardiac amyloidosis presenting as sick sinus syndrome and intractable heart failure: report of a case.
J Formos Med Assoc. 1993 Mar;92(3):283-7.
8
Cardiac amyloidosis - experience in a tertiary cardiac referral centre.心脏淀粉样变性——三级心脏转诊中心的经验
Int J Cardiol. 2008 Feb 29;124(2):264-6. doi: 10.1016/j.ijcard.2006.12.041. Epub 2007 Mar 23.
9
Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.心脏移植后继以剂量密集美法仑和自体干细胞移植治疗轻链淀粉样变性和心力衰竭。
Transplantation. 2010 Oct 27;90(8):905-11. doi: 10.1097/TP.0b013e3181f10edb.
10
A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies.一篇关于心脏淀粉样变性的诊断、心脏并发症治疗和疾病修饰治疗的最新进展的综述。
F1000Res. 2023 Feb 20;12:192. doi: 10.12688/f1000research.130285.1. eCollection 2023.

引用本文的文献

1
Advances in the Diagnosis and Management of Cardiac Amyloidosis: A Literature Review.心脏淀粉样变的诊断与管理进展：文献综述
Cardiol Res. 2024 Aug;15(4):211-222. doi: 10.14740/cr1664. Epub 2024 Jul 18.

本文引用的文献

1
Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study.心力衰竭患者的淀粉样变性与30天结局：一项全国再入院数据库研究
JACC CardioOncol. 2020 Dec 15;2(5):710-718. doi: 10.1016/j.jaccao.2020.10.007. eCollection 2020 Dec.
2
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis.心肌活检对射血分数保留心力衰竭的特征分析及心脏淀粉样变性的患病率。
JACC Heart Fail. 2020 Sep;8(9):712-724. doi: 10.1016/j.jchf.2020.04.007. Epub 2020 Jul 8.
3
Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
接受心脏移植的心脏淀粉样变性患者的结局。
JACC Heart Fail. 2020 Jun;8(6):461-468. doi: 10.1016/j.jchf.2019.12.013. Epub 2020 May 6.
4
Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.接受经导管主动脉瓣植入术患者的双主动脉瓣狭窄与心脏淀粉样变病理的患病率及预后
Eur Heart J. 2020 Aug 1;41(29):2759-2767. doi: 10.1093/eurheartj/ehaa170.
5
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis.治疗轻链和转甲状腺素蛋白淀粉样变性的新兴疗法
JACC Basic Transl Sci. 2019 Jun 24;4(3):438-448. doi: 10.1016/j.jacbts.2019.02.002. eCollection 2019 Jun.
6
Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.腕管综合征与淀粉样变性、心力衰竭和不良心血管结局的关联。
J Am Coll Cardiol. 2019 Jul 9;74(1):15-23. doi: 10.1016/j.jacc.2019.04.054.
7
Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.非对比磁共振成像在心脏淀粉样变性诊断中的应用。
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):69-80. doi: 10.1016/j.jcmg.2019.03.026. Epub 2019 Jun 12.
8
Seven factors predict a delayed diagnosis of cardiac amyloidosis.七种因素可预测心脏淀粉样变性的延迟诊断。
Amyloid. 2018 Sep;25(3):174-179. doi: 10.1080/13506129.2018.1498782. Epub 2018 Aug 31.
9
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
10
A new staging system for cardiac transthyretin amyloidosis.心脏转甲状腺素蛋白淀粉样变性的新分期系统。
Eur Heart J. 2018 Aug 7;39(30):2799-2806. doi: 10.1093/eurheartj/ehx589.